Pharma's Almanac TV
PA TV
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Pharma
80 Articles Available
0
4
Can't find what you're looking for? Try our
advanced search
.
Gene Therapy
Introduction: The Promise & Challenge of Gene Therapy
PAP-Q4-19-NI-008
Glocalization
Impacts of Glocalization on the Pharmaceutical Industry
PAP-Q3-19-NI-001
Glocalization
Introduction: Glocalization
PAP-Q3-19-NI-003
Growth
Lonza on Track to Deliver Full-Year 2019 Results, Driven by Pharma Biotech Business
PR-M07-19-NI-069
Advertising
Drug Companies Fight Back on TV Ad Pricing
PAO-M06-19-NI-019
Investigation
FBI Investigating Pharma Companies for Corruption in Brazil
PAO-M05-19-NI-025
Parenteral Solutions
Supporting Small and Emerging Pharma through Collaboration and Specialized Expertise
PAP-Q2-2019-CL-017
Supply Chain Solutions
Integrated Clinical Packaging, Warehousing and Transport Services Supporting Pharma and Biopharma
PAP-Q1-2019-CL-008
FDA Approval
U.S. Food and Drug Administration Approves Opdivo®(nivolumab) as the First New Medication in Nearly 20 Years for Certain Patients with Previously Treated Small Cell Lung Cancer
PR-M09-18-NI-065
Duchenne Muscular Dystrophy
Fight Against Duchenne Muscular Dystrophy Gets Major Funding Boost
PR-M09-18-NI-063
Drug Development
Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) and Opicapone at the 2018 World Congress on Parkinson's Disease and Related Disorders
PR-M09-18-NI-058
Study Results
Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
PR-M09-18-NI-059
NDA
Ortho Dermatologics Resubmits U.S. New Drug Application For DUOBRII™ (halobetasol propionate and tazarotene) Lotion
PR-M09-18-NI-057
Artificial Intelligence
WuXi AppTec Research Service Division and Cyclica Collaborate to Drive Polypharmacology in Drug Discovery Through AI-Augmented Technologies
PR-M09-18-NI-054
Preparing for Hurricane Florence in Pharma
PAO-M09-18-NI-013
FDA Approval
Sun Pharma Announces U.S. FDA Approval of CEQUA™ to Treat Dry Eye Disease
PR-M09-18-NI-053
Study Results
Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
PR-M09-18-NI-051
Approval
Trovagene Receives USAN Approval for "Onvansertib" as Nonproprietary Name for First-in-Class, 3rd Generation PLK1 Inhibitor Drug Candidate, PCM-075
PR-M09-18-NI-048
Oncology
GeneNews and LifeX™ Partner to Deliver Proprietary "Liquid Biopsy" Molecular Diagnostics to Health Systems to Detect Cancer at Earliest Stages
PR-M09-18-NI-047
Study Results
Janssen Reports Positive Topline Results for ATLAS Phase III Study of a Novel, Long Acting Injectable Two-Drug Regimen for the Treatment of HIV-1
PR-M09-18-NI-045
Drug Designation
Martin Pharmaceuticals’ LIVANTRA™ Receives FDA Orphan Drug Designation in Second Indication
PR-M09-18-NI-033
Orphan Drug Designation
FDA Grants Orphan Drug Designation to Onspira Therapeutics' Investigational Interleukin-1 Receptor Antagonist for the Treatment of Bronchiolitis Obliterans
PR-M09-18-NI-032
Injectables
Kaléo Confirms U.S. Availability of AUVI-Q® (epinephrine injection, USP) Auto-injector for Back-to-School Season
PR-M09-18-NI-023
Generics
Mylan Launches First Generic for Adcirca® Tablets
PR-M09-18-NI-021
«
0
4
»
